Session 6: Insights from Health Care Systems on Bispecifics: Patient Treatment, Monitoring and Transition of Care

home / training-academy / insights-from-healthcare-systems-and-bispecifics-patient-treatment-monitoring-and-transition-of

Binod Dhakal, MD, MS, and a panel of experts in multiple myeloma provide a look at an upcoming Cancer Network Training Academy program discussing how to incorporate bispecific antibodies in the treatment of multiple myeloma, and how healthcare systems implement step-up dosing, treatment doses and transition of care. The panel also offers insights into the recommended strategies for monitoring patients receiving treatment with bispecifics.